COPD Stakeholder Summit: Utilizing Peak Inspiratory Flow Rates to Individualize Treatment and Improve Outcomes

Neil Minkoff, MD

Prior to diving into a discussion on best practices for managing chronic obstructive pulmonary disease, stakeholders in health care remark on the prevalence and impact of the disease in the United States.

M. Bradley Drummond, MD, MHS

Challenges associated with inadequate use of inhalers to treat chronic obstructive pulmonary disease and their impact on patients and the health care system.

Donald A. Mahler, MD

A broad overview of the overall approach to managing chronic obstructive pulmonary disease with available treatment options.

M. Bradley Drummond, MD, MHS

Factors to consider when selecting an appropriate inhaler device to treat a patient with chronic obstructive pulmonary disease, and the role of measuring peak inspiratory flow to help determine one’s disease severity.

Donald A. Mahler, MD

Recommendations to clinicians who refer to and utilize the GOLD criteria to best treat patients with chronic obstructive pulmonary disease.

Donald A. Mahler, MD

Clinicians and a payer review current treatment guidelines for chronic obstructive pulmonary disease and discuss how often they refer to and utilize current recommendations when making decisions for coverage and treatment.

Maria Lopes, MD, MS

An overview of COPD management programs available and offered by payers to members to help support patient adherence to chronic obstructive pulmonary disease therapies.

Donald A. Mahler, MD

Strategies currently used to monitor patients’ adherence to chronic obstructive pulmonary disease treatment, and thoughts on incorporating smart inhalers into management.

Neil Minkoff, MD

Recommended best practices for working with patients who smoke to reduce the risk of chronic obstructive pulmonary disease progression.

Donald A. Mahler, MD

Considerations to help clinicians support patients with chronic obstructive pulmonary disease, especially during the pandemic, and to reduce social isolation associated with the disease.

M. Bradley Drummond, MD, MHS

Strategies that can be used to navigate through current barriers associated with screening patients for chronic obstructive pulmonary disease during the coronavirus pandemic.

Maria Lopes, MD, MS

Closing thoughts from a discussion between clinicians and a payer on best practices for identifying and treating patients with chronic obstructive pulmonary disease to optimize outcomes and improve care.

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo